Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden

Molecular Psychiatry

Volumn 10, Issue 2, 2005, Pages 220-224

  Grabe, H J ^a   Lange, M ^a   Wolff, B ^a   Volzke H ^a   Lucht, M ^a   Freyberger, H J ^a   John, U ^a   Cascorbi, I ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Chronic diseases; Gene environment interaction; Psychosocial stressors; Serotonin transporter promoter gene polymorphism; SHIP; SLC6A4

Indexed keywords

SEROTONIN TRANSPORTER;

ADULT; AGED; ALLELE; ANXIETY; ARTICLE; CHRONIC DISEASE; DEPRESSION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE; GENOTYPE ENVIRONMENT INTERACTION; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; NUCLEOTIDE SEQUENCE; PHYSICAL STRESS; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SCORING SYSTEM; SEX DIFFERENCE; SLC6A4 GENE; SOCIAL PROBLEM; SOCIAL PSYCHOLOGY; UNEMPLOYMENT;

ADAPTATION, PHYSIOLOGICAL; ADAPTATION, PSYCHOLOGICAL; ADULT; AGED; CHRONIC DISEASE; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEX FACTORS; STRESS; STRESS, PSYCHOLOGICAL;

EID: 13244260769     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001555     Document Type: Article

References (26)

1. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D et al. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996; 66: 2621-2624.
2. Heils A, Mossner R, Lesch KP. The human serotonin transporter gene polymorphism: basic research and clinical implications. J Neural Transm 1997; 104: 1005-1014.
3. Little KY, McLaughlin DP, Zhang L, Livermore CS, Dalack GW, McFinton PR et al. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am J Psychiatry 1998; 155: 207-213.
4. Collier DA, Stober G, Li T, Heils A, Catalano M, Di Bella D et al. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry 1996; 1: 453-460.
5. Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 1999; 88: 83-87.
6. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527-1531.
7. Cloninger CR, Przybeck TR, Svrakic DM. The Tridimensional Personality Questionnaire: U.S. normative data. Psychol Rep 1991; 69: 1047-1057.
8. Greenberg BD, Li Q, Lucas FR, Hu S, Sirota LA, Benjamin J et al. Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample. Am J Med Genet 2000; 96: 202-216.
9. Mazzanti CM, Lappalainen J, Long JC, Bengel D, Naukkarinen H, Eggert M et al. Role of the serotonin transporter promoter polymorphism in anxiety-related traits. Arch Gen Psychiatry 1998; 55: 936-940.
10. Ebstein RP, Gritsenko I, Nemanov L, Frisch A, Osher Y, Belmaker RH. No association between the serotonin transporter gene regulatory region polymorphism and the Tridimensional Personality Questionnaire (TPQ) temperament of harm avoidance. Mol Psychiatry 1997; 2: 224-226.
11. Flory JD, Munack SB, Ferrell RE, Dent KM, Peters DG, Muldoon MF. Neuroticism is not associated with the serotonin transporter (5-HTTLPR) polymorphism. Mol Psychiatry 1999; 4: 93-96.
12. Jorm AF, Henderson AS, Jacomb PA, Christensen H, Korten AE, Rodgers B et al. An association study of a functional polymorphism of the serotinin transporter gene with personality and psychiatric symptoms. Mol Psychiatry 1998; 3: 449-451.
13. Lesch KP In: Plomin R, DeFries JC, Craig IW, McGuffin P (eds). Behavioural Genetics in the Postgenomics Era. APA: Washington, DC, 2003 pp 389-424.
14. Neumeister A, Konstantinidis A, Stastny J, Schwarz MJ, Vitouch O, Willeit M et al. Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch Gen Psychiatry 2002; 59: 613-620.
15. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003; 18: 386-389.
16. John U, Greiner B, Hensel E, Lüdemann J, Piek M, Sauer S et al. Study of health in Pomerania (SHIP): a health examination survey in an east German region: objectives and design. Soz-Präventivmed 2001; 46: 186-194.
17. von Zerssen D, Koeller D. Beschwerden-Liste (Complaints Schedule). Beltz: Weinheim, 1976.
18. Bauer M, Priebe S, Berghofer A, Bschor T, Kiesslinger U, Whybrow PC. Subjective response to and tolerability of long-term supraphysiological doses of levothyroxine in refractory mood disorders. J Affect Disord 2001; 64: 35-42.
19. Baltes PB, Mayer KU (eds). The Berlin Aging Study: Aging From 70 to 100. Cambridge University Press: New York, 1999.
20. Sherbourne CD, Stewart AL. The MOS Social Support Survey. Social Sci Med 1991; 32: 705-714.
21. McDowell I, Newell C. Measuring health. A guide to rating scales and questionnaires. Oxford University Press: New York, 1996.
22. Brummett BH, Siegler IC, McQuaid DR, Svenson IK, Marchuk DA, Steffens DC. Associations among the NEO personality inventory, revised and the serotonin transporter gene-linked polymorphic region in elders: effect of depression and gender. Psychiatr Genet 2003; 13: 13-18.
23. Kruth HS. Platelet-mediated cholesterol accumulation in cultured aortic smooth muscle cells. Science 1985; 227: 1243-1245.
24. Golino P, Ashton JH, Buja LM, Rosolowsky M, Taylor AL, McNatt J et al. Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators. Circulation 1989; 79: 154-166.
25. Vikenes K, Farstad M, Nordrehaug JE. Serotonin is associated with coronary artery disease and cardiac events. Circulation 1999; 100: 483-489.
26. Arinami T, Ohtsuki T, Yamakawa-Kobayashi K, Amemiya H, Fujiwara H, Kawata K et al. A synergistic effect of serotonin transporter gene polymorphism and smoking in association with CHD. Thromb Haemost 1999; 81: 853-856.